Royal Bank of Canada’s OrthoPediatrics KIDS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $53K | Sell |
3,345
-208
| -6% | -$3.63K | ﹤0.01% | 5463 |
|
|
2025
Q4 | $64K | Sell |
3,553
-814
| -19% | -$14.3K | ﹤0.01% | 5423 |
|
|
2025
Q3 | $81K | Buy |
4,367
+18
| +0.4% | +$371 | ﹤0.01% | 5615 |
|
|
2025
Q2 | $93K | Sell |
4,349
-449
| -9% | -$9.71K | ﹤0.01% | 5646 |
|
|
2025
Q1 | $118K | Sell |
4,798
-431
| -8% | -$10.6K | ﹤0.01% | 5104 |
|
|
2024
Q4 | $122K | Sell |
5,229
-728
| -12% | -$18.2K | ﹤0.01% | 5210 |
|
|
2024
Q3 | $161K | Buy |
5,957
+97
| +2% | +$2.94K | ﹤0.01% | 4994 |
|
|
2024
Q2 | $168K | Buy |
5,860
+981
| +20% | +$30.1K | ﹤0.01% | 4901 |
|
|
2024
Q1 | $141K | Sell |
4,879
-5,812
| -54% | -$163K | ﹤0.01% | 4973 |
|
|
2023
Q4 | $347K | Sell |
10,691
-2,017
| -16% | -$58.5K | ﹤0.01% | 4596 |
|
|
2023
Q3 | $407K | Buy |
12,708
+936
| +8% | +$36.1K | ﹤0.01% | 4218 |
|
|
2023
Q2 | $517K | Sell |
11,772
-122
| -1% | -$5.63K | ﹤0.01% | 3928 |
|
|
2023
Q1 | $528K | Sell |
11,894
-672
| -5% | -$29.7K | ﹤0.01% | 3830 |
|
|
2022
Q4 | $499K | Buy |
12,566
+1,423
| +13% | +$59.3K | ﹤0.01% | 4111 |
|
|
2022
Q3 | $514K | Buy |
11,143
+75
| +0.7% | +$3.68K | ﹤0.01% | 4021 |
|
|
2022
Q2 | $478K | Sell |
11,068
-1,043
| -9% | -$47.7K | ﹤0.01% | 4128 |
|
|
2022
Q1 | $654K | Sell |
12,111
-1,783
| -13% | -$91.1K | ﹤0.01% | 4049 |
|
|
2021
Q4 | $832K | Buy |
13,894
+2,025
| +17% | +$126K | ﹤0.01% | 4000 |
|
|
2021
Q3 | $778K | Sell |
11,869
-421
| -3% | -$27.3K | ﹤0.01% | 3938 |
|
|
2021
Q2 | $776K | Buy |
12,290
+133
| +1% | +$7.64K | ﹤0.01% | 3879 |
|
|
2021
Q1 | $593K | Buy |
12,157
+216
| +2% | +$10.4K | ﹤0.01% | 4034 |
|
|
2020
Q4 | $492K | Buy |
11,941
+29
| +0.2% | +$1.33K | ﹤0.01% | 4150 |
|
|
2020
Q3 | $547K | Sell |
11,912
-205
| -2% | -$9.51K | ﹤0.01% | 3773 |
|
|
2020
Q2 | $530K | Buy |
12,117
+992
| +9% | +$44.6K | ﹤0.01% | 3722 |
|
|
2020
Q1 | $441K | Buy |
11,125
+5,872
| +112% | +$263K | ﹤0.01% | 3726 |
|
|
2019
Q4 | $247K | Buy |
5,253
+893
| +20% | +$34.6K | ﹤0.01% | 4495 |
|
|
2019
Q3 | $153K | Buy |
4,360
+2,016
| +86% | +$69.8K | ﹤0.01% | 4598 |
|
|
2019
Q2 | $91K | Buy |
2,344
+255
| +12% | +$10.3K | ﹤0.01% | 4931 |
|
|
2019
Q1 | $92K | Buy |
2,089
+349
| +20% | +$13.3K | ﹤0.01% | 4825 |
|
|
2018
Q4 | $60K | Buy |
1,740
+1,552
| +826% | +$49.2K | ﹤0.01% | 4998 |
|
|
2018
Q3 | $7K | Buy |
188
+162
| +623% | +$4.96K | ﹤0.01% | 6114 |
|
|
2018
Q2 | $1K | Sell |
26
-480
| -95% | -$10.2K | ﹤0.01% | 6362 |
|
|
2018
Q1 | $8K | Buy |
506
+6
| +1% | +$106 | ﹤0.01% | 5791 |
|
|
2017
Q4 | $10K | Buy |
+500
| New | +$9.56K | ﹤0.01% | 5862 |
|
Other funds holding KIDS
B
GIM
VCM
SCM
Royal Bank of Canada's KIDS Position: Q1 2026 in Review
Royal Bank of Canada reduced its OrthoPediatrics (KIDS) stake by 5.9% in Q1 2026, selling an estimated $3.63K and leaving 3,345 shares worth $53K. The position accounts for ﹤0.01% of the portfolio, ranked #5463.
Royal Bank of Canada first reported a position in KIDS in Q4 2017 and has held it in 34 quarters since. The position peaked at $832K in Q4 2021. 121 funds tracked by Wall St. Rank hold KIDS as of Q1 2026.
- Royal Bank of Canada held 3,345 shares of OrthoPediatrics worth $53K as of Q1 2026.
- Royal Bank of Canada sold 208 OrthoPediatrics shares in Q1 2026, an estimated $3.63K.
- OrthoPediatrics made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #5463 holding.
- Royal Bank of Canada first reported a position in OrthoPediatrics in Q4 2017 and has held it in 34 quarters since.
- Royal Bank of Canada's OrthoPediatrics position peaked at $832K in Q4 2021.
- 121 funds tracked by Wall St. Rank held OrthoPediatrics as of Q1 2026.
Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.